Bier's white spots associated with scleroderma renal crisis.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 17137483)

Published in Clin Exp Dermatol on November 27, 2006

Authors

I Peyrot1, S Boulinguez, A Sparsa, Y Le Meur, J-M Bonnetblanc, C Bedane

Author Affiliations

1: Department of Dermatology, Teaching Dupuytren University Hospital, Limoges, France. ipeyrot@yahoo.fr

Articles citing this

Bier spots. CMAJ (2012) 1.07

Cutaneous manifestations of common liver diseases. J Clin Exp Hepatol (2012) 0.77

Bier spots: An uncommon cause of mottled skin. Indian Dermatol Online J (2015) 0.75

Articles by these authors

Optimization of initial tacrolimus dose using pharmacogenetic testing. Clin Pharmacol Ther (2010) 2.94

Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol (1995) 2.37

Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice. Br J Cancer (1999) 1.96

Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol (1998) 1.70

[Does bullous pemphigoid with negative direct immunofluorescence exist? Apropos of 3 cases]. Ann Dermatol Venereol (1992) 1.40

Role of drug exposure in aphthous ulcers: a case-control study. Br J Dermatol (2000) 1.39

Regulation of erythropoiesis by bone marrow reninangiotensin system: facts and speculations. Exp Hematol (1998) 1.39

Hypokalemic quadriplegia and respiratory arrest revealing primary Sjögren's syndrome. Clin Nephrol (1992) 1.25

Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study. Am J Transplant (2009) 1.24

The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics. Clin Pharmacol Ther (2009) 1.22

Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids. Am J Transplant (2007) 1.22

Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol (1989) 1.21

Population pharmacokinetic modeling of oral cyclosporin using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimator. Ther Drug Monit (2004) 1.06

[Historic malignant tumour: 27 observations]. Ann Dermatol Venereol (2011) 1.06

Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol (1996) 1.04

Aortic angiosarcoma clinically mimicking polyarteritis nodosa. Scand J Rheumatol (2006) 1.02

High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. Am J Transplant (2010) 1.01

UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients. Clin Pharmacol Ther (2009) 0.98

Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus. Am J Transplant (2009) 0.97

[Giant buccal aphthosis caused by nicorandil]. Presse Med (1997) 0.96

Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial. Br J Dermatol (2012) 0.96

Donor P-gp polymorphisms strongly influence renal function and graft loss in a cohort of renal transplant recipients on cyclosporine therapy in a long-term follow-up. Clin Pharmacol Ther (2010) 0.95

Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera. Dermatology (2004) 0.95

Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrations. Am J Transplant (2015) 0.93

Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol (2011) 0.92

[Clinical characteristics, outcome of scleromyxoedema: a retrospective multicentre study]. Ann Dermatol Venereol (2010) 0.90

[Cutaneous drug reactions induced by glycopeptides]. Med Mal Infect (2007) 0.88

[Bacterial dermo-hypodermatitis in adults. Incidence and role of streptococcal etiology]. Ann Dermatol Venereol (1995) 0.88

Application of a gamma model of absorption to oral cyclosporin. Clin Pharmacokinet (2001) 0.86

Treatment of verrucous carcinoma with recombinant alfa-interferon. Dermatology (1995) 0.85

[Drug hypersensitive syndrome caused by fluindione]. Ann Dermatol Venereol (2001) 0.84

Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients. J Eur Acad Dermatol Venereol (2010) 0.84

High prevalence and risk factors of thromboembolism in stage IV melanoma. J Eur Acad Dermatol Venereol (2011) 0.84

A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry. BMC Genomics (2008) 0.84

Postoperative interstitial radiotherapy of keloids by iridium 192: a retrospective study of 46 treated scars. Dermatology (1997) 0.83

[Methi-resistant Staphylococcus aureus in dermatological practice: origin, risk factors and outcome]. Ann Dermatol Venereol (2002) 0.83

[Calciphylaxis treated by cinacalcet: a medical alternative to parathyroidectomy]. Rev Med Interne (2008) 0.83

[Physiopathology of bullous pemphigoid]. Ann Dermatol Venereol (2009) 0.83

Granulomatous dermatitis after implantation of a titanium-containing pacemaker. Contact Dermatitis (1995) 0.82

[Drug-induced hypersensitivity syndrome in internal medicine: diagnostic and therapeutic traps. Eight observations]. Rev Med Interne (2000) 0.82

[Verrucous carcinoma of the lower limbs]. Ann Dermatol Venereol (2007) 0.82

[Primary cutaneous large B-cell lymphoma in chronic venous leg ulcer]. Ann Dermatol Venereol (2007) 0.81

[Bevacizumab therapy for Poems syndrome]. Ann Dermatol Venereol (2008) 0.81

Renal involvement in Wegener's granulomatosis. Clin Rev Allergy Immunol (2008) 0.81

[Survival prognosis in pemphigoid. A cohort analysis of 78 patients]. Ann Dermatol Venereol (1995) 0.81

[Pemphigoid vegetans. An immunoelectron microscopic study]. Ann Dermatol Venereol (1997) 0.81

A proliferative vascular tumour of the skin in a kidney-transplant recipient (recurrent pyogenic granuloma with satellitosis). Nephrol Dial Transplant (1997) 0.81

Neutrophilic dermatosis: a case of overlapping syndrome with monoclonal antineutrophil cytoplasmic autoantibody activity. Dermatology (1994) 0.81

Thalidomide and recurrent aphthous stomatitis: a follow-up study. Dermatology (1996) 0.80

Hepatitis B screening: who to target? A French sexually transmitted infection clinic experience. J Hepatol (2012) 0.80

Feasibility of, and critical paths for mycophenolate mofetil Bayesian dose adjustment: pharmacological re-appraisal of a concentration-controlled versus fixed-dose trial in renal transplant recipients. Pharmacol Res (2009) 0.80

[The value of photodynamic therapy in the treatment of Bowen's disease]. Ann Dermatol Venereol (2008) 0.80

Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. J Invest Dermatol (1990) 0.79

Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation. Transplant Proc (2006) 0.79

Accuracy and repeatability of the Polar RS800sd to evaluate stride rate and running speed. Int J Sports Med (2009) 0.79

Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach. Pharmacol Res (2013) 0.78

[Methicilline-sensitive and methicilline-resistant Staphylococcus aureus related morbidity in chronic wounds: a prospective study]. Ann Dermatol Venereol (2003) 0.78

[Bullous pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]. Ann Dermatol Venereol (2011) 0.78

[Prenatal diagnosis of hereditary bullous epidermolysis. A case report]. J Gynecol Obstet Biol Reprod (Paris) (1996) 0.78

Development of enzymo-immunoassays (EIA) for macrophage colony-stimulating factor (M-CSF) and leukaemia inhibitory factor (LIF) by using the same capture and signal generating polyclonal antibody. Cytokine (1996) 0.78

[Intra-epidermal neutrophilic IgA dermatosis associated with IgA myeloma]. Ann Dermatol Venereol (1990) 0.77

[Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)]. Ann Dermatol Venereol (2003) 0.77

[Photodynamic therapy for the treatment of extramammary Paget's disease]. Ann Dermatol Venereol (2011) 0.77

Acquired ichthyosis with pravastatin. J Eur Acad Dermatol Venereol (2007) 0.77

Endurance and strength training effects on physiological and muscular parameters during prolonged cycling. J Electromyogr Kinesiol (2009) 0.77

Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients. Br J Dermatol (1997) 0.77

[Gardasil®-induced erythema nodosum]. Rev Med Interne (2011) 0.77

[Cutaneous reactions to gold salts]. Ann Dermatol Venereol (1994) 0.76

[Bullous pemphigoid in young patients: a retrospective study of 74 cases]. Ann Dermatol Venereol (2005) 0.76

Urticaria with macroglobulinaemia. Disease activity associated alterations in immunoglobulins profile and bone marrow hypodiploidy. Dermatologica (1990) 0.76

Bullous lichen sclerosus with chronic hepatitis C virus infection. Br J Dermatol (1997) 0.76

[Analysis of the literature about drug-induced aphthous ulcers]. Ann Dermatol Venereol (2000) 0.76

Increased levels of serum macrophage colony stimulating factor (M-CSF or CSF-1) in patients with chronic renal insufficiency (CRF): facts and hypotheses. Cytokine (1995) 0.75

[Sensitive chronic inflammatory demyelinating polyradiculoneuropathy in Schnitzler's syndrome]. Ann Dermatol Venereol (2003) 0.75

Adverse effects associated with EMLA cream used as topical anesthetic for the mechanical debridement of leg ulcers. J Am Acad Dermatol (2000) 0.75

Is plasma Ac-SDKP level a reliable marker of chronic angiotensin-converting enzyme inhibition in hypertensive patients? Hypertension (1998) 0.75

The influence of cytomegalovirus infections on patient and renal graft outcome: a 3-year, multicenter, observational study (Post-ECTAZ Study). Transplant Proc (2011) 0.75